Cylindromatosis (Turban Tumor Syndrome) (CYLD) Peptide
-
- Target See all CYLD products
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
- Origin
- Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- DSQQSKSKNP WYIDE
- Characteristics
- The peptide was used in the production of ABIN368928 - Goat Anti-Cyld (mouse) Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- CYLD (Cylindromatosis (Turban Tumor Syndrome) (CYLD))
- Synonyms
- BRSS Peptide, CDMT Peptide, CYLD1 Peptide, CYLDI Peptide, EAC Peptide, MFT Peptide, MFT1 Peptide, SBS Peptide, TEM Peptide, USPL2 Peptide, 2010013M14Rik Peptide, 2900009M21Rik Peptide, C130039D01Rik Peptide, mKIAA0849 Peptide, cyld Peptide, LRRGT00003 Peptide, Rp1 Peptide, Rp1h Peptide, CYLD lysine 63 deubiquitinase Peptide, cylindromatosis (turban tumor syndrome), a Peptide, CYLD Peptide, Cyld Peptide, cylda Peptide
-